Erik S. Stroes

Amsterdam, NH 1105AZ, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 377 publications

Multi-marker inflammatory risk assessment after acute coronary syndrome.

Multi-marker inflammatory risk assessment after acute coronary syndrome.

Journal: European heart journal
Published: August 20, 2026

Defining inflammation in cardiovascular risk: A complex challenge.

Defining inflammation in cardiovascular risk: A complex challenge.

Journal: Progress in cardiovascular diseases
Published: August 19, 2026

Taking the Sting Out of Lipoprotein(a): Oxidized Phospholipid Lowering With Lepodisiran.

Taking the Sting Out of Lipoprotein(a): Oxidized Phospholipid Lowering With Lepodisiran.

Journal: Journal of the American College of Cardiology
Published: July 21, 2026

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Journal: Journal of comparative effectiveness research
Published: June 19, 2026

Efficacy and safety of olezarsen in patients with vs without baseline fibrate use.

Efficacy and safety of olezarsen in patients with vs without baseline fibrate use.

Journal: Journal of clinical lipidology
Published: May 13, 2026

Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Journal: Circulation
Published: March 30, 2026

ApoC-III inhibition: from regulatory approval to equitable implementation.

ApoC-III inhibition: from regulatory approval to equitable implementation.

Journal: Nature reviews. Cardiology
Published: March 25, 2026

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Journal: Atherosclerosis
Published: March 18, 2026

Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohort.

Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohort.

Journal: American journal of preventive cardiology
Published: February 08, 2026

Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development.

Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development.

Journal: Atherosclerosis
Published: February 02, 2026

Combined LDL-C, Lp(a), and hsCRP Assessment Predicts ASCVD in the Multiethnic HELIUS Cohort.

Combined LDL-C, Lp(a), and hsCRP Assessment Predicts ASCVD in the Multiethnic HELIUS Cohort.

Journal: Journal of the American College of Cardiology
Published: January 28, 2026

Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry.

Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry.

Journal: Atherosclerosis
Published: December 30, 2025
Showing 1-12 of 377

Last Updated: 09/26/2026